ArticleThe International journal of eating disorders2025
Toward Integrated Treatment for Co-Occurring Borderline Personality Disorder and Eating Disorders: A Clinician Perspective.
Article in The International journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Body as a Battlefield: Identity Development and Psychosomatic Expression in Eating Disorders Across Childhood and Adolescence.Children (Basel, Switzerland) · 2025Review
- A shift or a substitution? On naming, exclusion, and co-production in longstanding eating disorders: matters arising from Lubieniecki et al. (2025).Journal of eating disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIt is common practice in Australia for co-occurring borderline personality disorder (BPD) and eating disorders (ED) to be treated separately. The objective of this research was to review features these disorders share, evidence-based approaches used for treating these disorders in isolation, clinicians' experiences of delivering treatment for co-occurring BPD and ED, and finally to explore integrated approaches to treating this dual diagnosis.
methodA qualitative approach was used to examine interview transcripts of 10 clinicians employed at specialist outpatient services for severe BPD or severe ED. Interview transcripts were analyzed using thematic analysis.
resultsNominated features shared by BPD and ED were emotion dysregulation, impulsivity, and interpersonal difficulties. Clinicians endorsed a range of therapeutic approaches for this dual diagnosis patient group, as well as an eclectic approach utilizing a combination of treatment features. Most clinicians proposed an ideal program duration of 6-12 months, with group and individually focused therapy complementing one another to address underlying behavioural drivers and confer lasting clinical benefits. DISCUSSION: This study distills the importance of adopting integrated treatments for people with this dual diagnosis to optimize treatment outcomes. Future research could include soliciting client perspectives on using an integrated treatment approach for this dual diagnosis and trials of this approach to assess acceptability, feasibility, and longer-term outcomes. PUBLIC SIGNIFICANCE STATEMENT: This study highlights the merit of concurrently addressing the complex interplay between EDs and BPD via an integrated treatment approach. Streamlining the therapeutic approach can address underlying features of these disorders, improve clinical formulation, and optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.